Post by Admin on Aug 1, 2013 8:03:37 GMT 7
สาระประโยชน์จากโคเอ็นไซม์ คิวเท็น (ไม่ควรทานมาก ไม่ควรทานต่อเนื่องนาน)
Previous
research has demonstrated that oxidative stress and impaired
antioxidant defense contribute to pathogenesis and progression of type 2
diabetes. It has also been shown that diabetic patients typically have
reduced coenzyme Q10 levels.
In a recent study published in in the journal Minerva Gastroenterolica e Dietolgica,
researchers compared the effect of coenzyme Q10 versus placebo on
glycemic control and lipid profile in type 2 diabetic patients.
The study included 64 adults between the ages of 20 and 60 who had
been diagnosed with type 2 diabetes. Participants received either 200 mg
of CoEnzyme Q10 or a placebo daily for 12 weeks. Blood samples were
collected at the beginning and the end of the trial and were analyzed
for fasting glucose, hemoglobin A1C, and lipids.
No significant changes in measurements were seen in the placebo
group, but serum hemoglobin A1C (a measure of long-term glucose
control), total cholesterol and LDL cholesterol were reduced in the
group taking the CoEnzyme Q10. No significant difference in fasting
glucose, triglycerides or HDL cholesterol were seen in either group.
The blood glucose fluctuations that occur in diabetics increase
potential free radical damage, which in turn may worsen diabetic
complications. Since diabetics are typically low in CoEnzyme Q10 levels,
the research suggests that supplementation may help restore normal
antioxidant defenses and protect pancreatic beta cells from excessive
oxidative damage.
Although more research is needed to confirm these results, this
study suggests that 12 weeks of CoEnzyme Q10 supplementation may improve
glycemic control, total cholesterol and LDL cholesterol in adult type 2
diabetics.
Kolahdouz Mohammadi R et al. The effect of coenzyme Q10
supplementation on metabolic status of type 2 diabetic patients.
Minerva Gastroenterol Dietol. 2013 Jun;59(2):231-6.
Previous
research has demonstrated that oxidative stress and impaired
antioxidant defense contribute to pathogenesis and progression of type 2
diabetes. It has also been shown that diabetic patients typically have
reduced coenzyme Q10 levels.
In a recent study published in in the journal Minerva Gastroenterolica e Dietolgica,
researchers compared the effect of coenzyme Q10 versus placebo on
glycemic control and lipid profile in type 2 diabetic patients.
The study included 64 adults between the ages of 20 and 60 who had
been diagnosed with type 2 diabetes. Participants received either 200 mg
of CoEnzyme Q10 or a placebo daily for 12 weeks. Blood samples were
collected at the beginning and the end of the trial and were analyzed
for fasting glucose, hemoglobin A1C, and lipids.
No significant changes in measurements were seen in the placebo
group, but serum hemoglobin A1C (a measure of long-term glucose
control), total cholesterol and LDL cholesterol were reduced in the
group taking the CoEnzyme Q10. No significant difference in fasting
glucose, triglycerides or HDL cholesterol were seen in either group.
The blood glucose fluctuations that occur in diabetics increase
potential free radical damage, which in turn may worsen diabetic
complications. Since diabetics are typically low in CoEnzyme Q10 levels,
the research suggests that supplementation may help restore normal
antioxidant defenses and protect pancreatic beta cells from excessive
oxidative damage.
Although more research is needed to confirm these results, this
study suggests that 12 weeks of CoEnzyme Q10 supplementation may improve
glycemic control, total cholesterol and LDL cholesterol in adult type 2
diabetics.
Kolahdouz Mohammadi R et al. The effect of coenzyme Q10
supplementation on metabolic status of type 2 diabetic patients.
Minerva Gastroenterol Dietol. 2013 Jun;59(2):231-6.
